Bc Powder
NDC Package 63029-992-06
Package Information
Bc (aspirin and caffeine) powders is adults and children 12 years of age and over: place 1 powder on tongue every 6 hours, while symptoms persist. This formulation utilizes a powder delivery system. Marketed by Medtech Products Inc., this product is identified by NDC 63029-992 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 1247402 - BC Fast Pain Relief 845 MG / 65 MG Oral Powder
- RxCUI: 1247402 - aspirin 845 MG / caffeine 65 MG Oral Powder [BC Original Formula]
- RxCUI: 1247402 - ASA 845 MG / Caffeine 65 MG Oral Powder [BC Original Formula]
- RxCUI: 1247402 - BC Pain Relief (ASA 845 MG / caffeine 65 MG) Oral Powder
- RxCUI: 994435 - aspirin 845 MG / caffeine 65 MG Oral Powder
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
- Central Nervous System Stimulation - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Methylxanthine - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Xanthines - [CS]
Regulatory & Marketing
Hierarchy Structure
- 63029 - Medtech Products Inc.
- 63029-992 - Bc
- 63029-992-06 - 6 POWDER in 1 PACKAGE
- 63029-992 - Bc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63029-992). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63029-992-06 identifies a specific commercial package of 6 powder in 1 package of Bc, a human over the counter drug labeled by Medtech Products Inc.. This powder is formulated for oral use and contains aspirin; caffeine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medtech Products Inc. on June 01, 2012. The current certification is valid through December 31, 2026.
How is this Medtech Products Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63029099206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.